Prevalence of Generic Subsidiaries to Increase 75% by 2010

RESEARCH TRIANGLE PARK, NC--(Marketwire - February 5, 2008) - Over the next two to three years, the number of brand-owned generic subsidiaries is expected to grow by 75%, according a recent study released by industry leader Cutting Edge Information. The study, which examines options for protecting brand products against generics, is located at: http://www.PharmaGenerics.com.

"In the past, generic subsidiaries have typically been limited to only the biggest industry players, but now smaller companies are venturing into the area as well," says Eric Bolesh, research team leader at Cutting Edge Information. "Companies that previously stayed away from the generics market are stepping up to bat."

Although generic subsidiaries are still less prominent than scientific options, such as new formulations and next generation products, their wide adoption represents a new step for the pharmaceutical industry. Authorized generics, as well, are expected to become more widely embraced: the study predicts that their use will increase by 33% by 2010.

Cutting Edge Information's report, "Combating Generics 2008: Counter Generics Strategy, Planning and Execution," available at http://www.PharmaGenerics.com, details the present and planned future usage of a dozen generics strategies and examines other counter-generics activity at more than 30 different companies. Data detail investment levels, planning and implementation timelines and the prominence of different tools and tactics in the fight against generics. The report's findings also explore case studies and the experiences of real-world brand teams.

Download a free summary of this 159-page report at: http://www.cuttingedgeinfo.com/pharmagenerics/PH105_Download.asp#body.

Contact Information: CONTACT: Oveda Slade 919-403-6583